Paz-Ares L, et al. Overall survival with durvalumab plus etoposide-platinum in first-line extensive-stage SCLC: results from the CASPIAN study. Abstract PL02.11. WCLC 2019, 7-10 september, Barcelona, Spanje.
Slim horloge helpt kinderen met hypothalame dysfunctie bij suprasellaire hersentumor
sep 2024 | Neuro-oncologie